DCOIWA’s state-wise training program for drug regulators begins

Besides, the workshop will help the inspectors and ADCs acquire and develop the information and skills to advance professionally and personally.

224
DCOIWA
DCOIWA

Last Updated on December 2, 2022 by The Health Master

Aimed at educating the working drug regulatory officers, especially the new entrants, in the area of monitoring compliance with drug laws by the manufacturing and trade industries, the Drugs Control Officers (I) Welfare Association (DCOIWA) is starting intensive training programs for the enforcement officers across the country.

The program is conducted in each state in association with the respective drug control administrations (DCA).

The first one in the series will kick off on December 5 in Jammu and Kashmir, where regulatory officers from Jammu & Kashmir (J&K) and Ladakh will take part.

The inauguration of the training program will be done by the J&K Drug Controller Jyothika Kajuria, sources from DCOIWA informed.

G. Koteshwar Rao, national president of the Drugs Control Officers (I) Welfare Association (DCOIWA), stated that the workshop covers four major areas that a drug regulator should understand in his professional service and that must be updated on a regular basis.

These areas are put into four modules in the structure of the workshop. These are:

  • The investigation process of counterfeit drugs,
  • Legal writing skills in FDA regulatory affairs,
  • Medical devices regulation in India
  • Regulatory requirements for drug labeling.

First EC meeting of DCOIWA held at pink city Jaipur


Talking about the country-wide training program, he said the workshop will reinforce the skills and the duty-bound spirit of the enforcement officers.

Besides, the workshop will help the inspectors and ADCs acquire and develop the information and skills to advance professionally and personally.

Every year one training program will be conducted under the initiative of DCOIWA.

“The workshop is designed in such a way that it will provide the legal knowledge and technical skill needed for monitoring regulatory compliance by manufacturers and traders, as well as rules and regulations applicable to the distribution and sale of pharmaceuticals in the open market and in hospitals.

Further, the workshop will make the participant become proficient in regulating the production and sale of all kinds of pharma and medical devices,” he added.

On December 5 in J&K, the program will be held at the drug control office from 9 a.m. onwards.

Retired joint commissioner from Maharashtra FDA, Dr. Om Prakash Advani, will take the class on the investigation of counterfeit drugs, and Rajendra Kumar Harna, retired ADC from FDA Haryana, will lead the session on legal writing of regulatory affairs.

In the afternoon, Lalit Kr. Goel, Asstt. State Drug Controller, FDA Haryana, will lead two sessions, one on the regulation of medical devices and another on the labeling of drugs.

NPPA fixes Retail Price of one formulation: November 2022

CDSCO gives approval for this Anti-diabetic drug

NPPA releases draft working sheets for ceiling price fixation of 954 formulations

USFDA gives nod for Levothyroxine Sodium For Injection

CDSCO gives nod to Dapagliflozin Tablets

Pharmacists deserve more recognition for their work

USFDA designates Cipla’s Goa plant as ‘OAI’

NPPA fixes Retail Price of 40 formulations: November 2022

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news